Loading...
DOCUMENTS
21
NOTICES
32
MOTS CLES
Monitoring
Cancer
Colectomy
Alkylating agents
MORTALITY
RISK
Bacteria
Colorectal cancer
Microbiote
Immune cells
Bactéries
Heart disease risk factors
Patients experience
Venous thromboembolism
Méthylation
Dysbiose
Stricture
IL12
Crohn's disease
Therapeutics
Anti-TNF
Contraindication
Helicobacter pylori
Disability
MALT
Small molecules
Gene expression
Inflammatory bowel disease
DNA methylation
Fecal microbiota
Algorithm
Resistance
Clinical trial
Neoadjuvant chemotherapy
Disease progression
Colon cancer
COLON-CANCER
Inhibitor
Tailored therapy
Epigenetics
Drug
Inclusion
Consensus
Gènes
Biologics
Survival
Biomarker
Ustekinumab
Over 80s
Genes
Epigénétiques
Rituximab plus chlorambucil
T1118 translocation
Parvimonas micra
Original Article Clinical
Clinical guidelines
MICROBIOTA
Dysbiosis
Microbiota
Colonic epithelial primary cells
Anti-TNF agents
Patient-reported outcome
Cell adhesion
Eradication
Disease Progression
Eligibility
Acceptability
Upper gastrointestinal tract
Colorectal cancer Colibactin and lipids
Immunosuppressant
Vedolizumab
Ulcerative colitis
Methylation
Colon
Rituximab
Maintenance therapy
Screening
Tuberculosis
Inflammatory bowel diseases
IBD
Gene methylation
18 FDG-PET/CT
HIV
Thérapie ciblée
DNA METHYLATION
Résistance
Safety
Intestinal crypts
CARCINOGENESIS
Crohn’s disease
Inflammatory Bowel Diseases
MARKER
IL23
Cost effectiveness
PCR
Kidney diseases
Effectiveness
Primary sclerosing cholangitis
Endoscopic treatment
Surgery
Early detection of Colon Cancer using Molecular Markers and Microbiota , EA 7375 | |
---|---|
Institutions |
UPEC |
Adresse |
Université Paris-Est Créteil Groupe Hospitalier Henri Mondor Service de Gastroentérologie 51 Av Maréchal de Lattre de Tassigny 94010 Créteil cedex |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Aurélien AMIOT |
Adjoint |
Iradj SOBHANI |
Axe(s) de recherche
|
Le laboratoire axe ses recherches sur le rôle du microbiome intestinal ainsi que des changements épigénétiques dans l'intestin afin :
|